CAS: 442908-10-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Vipadenant REF: AN-AG0039VLCAS: 442908-10-3 | 98% | A consultar | Vie 10 May 24 |
 | Vipadenant REF: TM-T2373CAS: 442908-10-3 | 98% | 40,00 €~1.105,00 € | Vie 17 May 24 |
 | Vipadenant REF: 3D-SSA90810CAS: 442908-10-3 | Min. 95% | A consultar | Vie 21 Jun 24 |
Ref: AN-AG0039VL
| 1g | A consultar | |
| 2mg | 47,00 € | |
| 5mg | 70,00 € | |
| 10mg | 115,00 € | |
| 25mg | 187,00 € | |
| 50mg | 226,00 € | |
| 100mg | 510,00 € | |
| 250mg | 611,00 € |
Entrega estimada en Estados Unidos, el Viernes 10 de Mayo de 2024
Vipadenant
CAS:442908-10-3
Vipadenant (CEB-4520)(BIIB-014) is an adenosine A2a antagonist with Ki of 1.3 nM; less potent for …
Fórmula:
C16H15N7O
Pureza:
98%
Forma y color:
Solid
Peso molecular:
321.34
Ref: TM-T2373
| 1mg | 40,00 € | |
| 2mg | 57,00 € | |
| 5mg | 90,00 € | |
| 10mg | 123,00 € | |
| 25mg | 211,00 € | |
| 50mg | 348,00 € | |
| 100mg | 515,00 € | |
| 500mg | 1.105,00 € | |
| 1ml*10 (DMSO) | 352,00 € |
Entrega estimada en Estados Unidos, el Viernes 17 de Mayo de 2024
Vipadenant
CAS:442908-10-3
Vipadenant is a new drug that has been developed for the treatment of cancer. It …
Fórmula:
C16H15N7O
Pureza:
Min. 95%
Peso molecular:
321.34 g/mol
Ref: 3D-SSA90810
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 21 de Junio de 2024
